Healthcare -
Biotechnology - NASDAQ - US
$ 4.65
-9.71 %
$ 414 M
Market Cap
-1.05
P/E
AMLX - REVENUE
Revenue AMLX - Amylyx Pharmaceuticals, Inc.
87.4 M
LAST VALUE
98.25%
2 YEAR CAGR
127.75%
5 YEAR CAGR
0.00%
10 YEAR CAGR